MedPath

Investigating the effect of increasing the amount of prescribed progesterone on the pregnancy success rate

Phase 3
Conditions
Female infertility
Female infertility.
Registration Number
IRCT20150105020558N6
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
218
Inclusion Criteria

Women with a three-layered endometrial pattern with sufficient thickness (7 mm) after receiving estrogen
Progesterone level less than 9.2 ng/ml on the day of transfer
With at least two three-day frozen embryos of good quality (AA, AB, BB)

Exclusion Criteria

The presence of underlying diseases such as malignancy, advanced heart failure, cirrhosis, progressive chronic neurological diseases, and uterine disorders such as fibroids, polyps, or hydrosalpinx.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ive birth. Timepoint: Once, after pregnancy termination. Method of measurement: The number of deliveries that resulted in a live-born neonate.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath